Sai Life Sciences

765.25
+37.20
(5.11%)
Market Cap
15,150.70 Cr
EPS
4.57
PE Ratio
89.47
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
808.80
52 Week Low
636.10
PB Ratio
7.15
Debt to Equity
1.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from3 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+33.33 %
+33.33 %
Hold
Hold+33.33 %
+33.33 %
Sell
Sell+33.33 %
+33.33 %

Company News

View All News
Caret
positive
SAI Life Sciences has commenced commercial operations for phase two at its Bidar Unit IV facility. This expansion has increased the company's total capacity to 640 KL. The news indicates a significant expansion in the company's production capabilities.
neutral
A block deal involving 10% equity (2.08 crore shares) of Sai Life Sciences occurred. TPG Asia, holding 24.73% stake, is likely selling 6% (12.5 million shares) at ₹710 per share, totaling $102 million. The company projects 15-20% revenue CAGR over 3-5 years with margin increase from 24% to 30%.
neutral
TPG Asia plans to sell a 6% stake in Sai Life Sciences through block deals. The sale involves 12.5 million shares at ₹710 per share, a 2.5% discount to the current market price. The deal is valued at approximately $102 million with a 60-day lock-in period for the seller post-transaction.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,665.10
#1 3,95,314.40
34.46
#1 49,887.20
12.06
#1 9,648
-18.99
43.07
6,592.00
1,72,368.70
78.68
8,184.00
0.89
1,600
23.05
54.72
1,499.70
1,19,850.10
22.72
26,520.70
14.17
4,155
30.28
51.10
1,325.30
1,10,657.10
19.57
28,905.40
12.36
5,578
21.14
63.98
3,167.20
1,07,084.10
55.61
10,785.70
11.59
1,656
10.91
44.26
2,288.80
95,932.80
48.26
10,615.60
19.57
1,942
-10.91
31.53
957.10
95,597.30
20.47
19,831.50
13.82
3,831
-0.19
58.53
1,948.00
88,194.60
26.89
20,141.50
#1 19.94
1,936
#1 112.49
43.17
31,620.00
65,936.60
46.59
6,097.20
10.80
1,201
27.83
57.00
1,097.20
62,871.80
#1 18.21
29,559.20
17.55
3,169
-0.50
36.07
Forecast
Actual
Growth Rate
Revenue Growth
20.01 %
Net Income Growth
728.00 %
Cash Flow Change
19.91 %
ROE
658.04 %
ROCE
94.05 %
EBITDA Margin (Avg.)
-

Quarterly Financial Results

Quarterly Financials
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
395
443
288
406
449
589
Expenses
287
315
254
293
320
422
EBITDA
108
128
34
112
129
167
Operating Profit %
25 %
28 %
9 %
26 %
27 %
27 %
Depreciation
31
31
31
36
34
38
Interest
23
21
21
21
23
11
Profit Before Tax
53
76
-18
55
72
119
Tax
13
20
-5
14
18
31
Net Profit
40
56
-14
42
54
88
EPS in ₹
2.19
31.00
0.00
2.22
2.89
4.24

Balance Sheet

Balance Sheet
2023
2024
Total Assets
2,187
2,275
Fixed Assets
1,037
1,180
Current Assets
964
945
Capital Work in Progress
151
107
Investments
2
2
Other Assets
997
987
Total Liabilities
2,187
2,275
Current Liabilities
759
740
Non Current Liabilities
540
560
Total Equity
888
975
Reserve & Surplus
870
957
Share Capital
18
18

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
Net Cash Flow
239
-150
-1
75
-80
-24
Investing Activities
-158
-262
-260
-102
-99
-191
Operating Activities
129
116
-36
105
219
263
Financing Activities
268
-4
296
72
-201
-95

Share Holding

% Holding
Jul 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
39.64 %
35.24 %
35.24 %
35.17 %
FIIs
0.00 %
7.64 %
11.72 %
12.36 %
DIIs
0.00 %
5.61 %
11.95 %
13.26 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
18.68 %
8.88 %
7.69 %
Others
60.36 %
32.84 %
32.22 %
31.52 %
No of Share Holders
70
5,72,970
82
1,40,677

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
13 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 May 2025 717.70 713.35
06 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2025 695.75 694.80

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation6 hours ago
Intimation For Commencement Of Commercial Operation Of The Second Phase Of The Production - (Unit IV Bidar Facility)7 hours ago
Announcement under Regulation 30 (LODR)-Change in Directorate3 days ago
Ratification Of ESOP Scheme And Extension Of Benefits To The Employees Of Its Subsidiaries.3 days ago
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report3 days ago
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation6 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation6 days ago
Reply To Ingovern Research Services Pvt Ltd On Recommendation Of Postal Ballot Notice (Under Of SEBI (Issue Of Capital And Disclosure Requirements) Regulations 201810 days ago
Announcement under Regulation 30 (LODR)-AllotmentJun 09, 2025
Reply To SES On Recommendation Of Postal Ballot Notice (Under Of SEBI (Issue Of Capital And Disclosure Requirements) Regulations 2018Jun 09, 2025
Reply To Iias On Recommendation Of Postal Ballot Notice (Under Of SEBI (Issue Of Capital And Disclosure Requirements) Regulations 2018Jun 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 03, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 26, 2025
Announcement under Regulation 30 (LODR)-AllotmentMay 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 23, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 15, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMay 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 14, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 14, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 14, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 14, 2025
Announcement under Regulation 30 (LODR)-AllotmentMay 14, 2025
Approved Notice Of Postal BallotMay 14, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 14, 2025
Results- Financial Results For The Period Ending 31St March 2025May 14, 2025
Board Meeting Outcome for Approval Of Financial Results For The Financial Year Ending 31.03.2025May 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 06, 2025
Board Meeting Intimation for Notice Of Board MeetingMay 06, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateApr 28, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementApr 23, 2025
Announcement under Regulation 30 (LODR)-AllotmentApr 23, 2025
Clarification On Increase In VolumeApr 16, 2025
Clarification sought from Sai Life Sciences LtdApr 16, 2025
Compliance Certificate For The Period Ending March 31 2025Apr 11, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 11, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 03, 2025
This Is To Inform You That A Notice Of Demand Was Issued By The Income Tax Department On 26 March 2025 Raising A Demand U/S 156 Of The Income Tax Act 1961.Mar 27, 2025
Announcement under Regulation 30 (LODR)-AllotmentMar 27, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 25, 2025
Announcement under Regulation 30 (LODR)-AllotmentMar 24, 2025

Technical Indicators

RSI(14)
Neutral
46.24
ATR(14)
Volatile
30.98
STOCH(9,6)
Neutral
31.43
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-3.10
ADX(14)
Strong Trend
31.18
UO(9)
Bearish
34.31
ROC(12)
Downtrend And Accelerating
-0.21
WillR(14)
Oversold
-86.59

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Nippon India Multi Cap Fund Direct-Growth
0.25%
440646
0.08%
0.06%
Kotak Manufacture in India Fund Direct - Growth
0.00%
-381304
-1.15%
-1.28%
Nippon India Small Cap Fund Direct- Growth
0.33%
200000
0.03%
-0.02%
Nippon India Pharma Fund Direct-Growth
1.40%
114756
0.19%
0.05%
Kotak MNC Fund Direct-Growth
0.24%
-96845
-0.30%
-0.37%
Kotak Balanced Advantage Fund Direct - Growth
0.00%
-87185
-0.04%
-0.06%
Mahindra Manulife Balanced Advantage Fund Direct - Growth
0.00%
-82919
-0.65%
-0.73%
Axis India Manufacturing Fund Direct-Growth
0.54%
72900
0.12%
0.18%
UTI Healthcare Fund Direct-Growth
0.72%
-69699
-0.43%
-0.63%
Kotak Healthcare Fund Direct - Growth
2.18%
-25000
-0.34%
-0.59%
Invesco India Flexi Cap Fund Direct - Growth
1.50%
20450
0.06%
0.25%
Aditya Birla Sun Life Retirement Fund - The 40s Plan Direct-Growth
2.63%
-10774
-0.52%
-2.20%
PGIM India Healthcare Fund Direct-Growth
1.32%
4410
0.38%
0.26%
ITI Pharma and Healthcare Fund Direct - Growth
1.02%
3030
0.17%
-0.04%
Mahindra Manulife Flexi Cap Fund Direct - Growth
0.00%
-1925
-0.01%
-0.01%
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth
0.19%
1128
0.00%
-0.02%
SBI Nifty Smallcap 250 Index Fund Direct - Growth
0.19%
667
0.00%
-0.02%
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth
0.19%
475
0.00%
-0.02%
Mirae Asset Aggressive Hybrid Fund Direct-Growth
0.40%
-471
0.02%
-0.02%
Nippon India Nifty 500 Equal Weight Index Fund Direct-Growth
0.19%
-342
0.00%
-0.02%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.19%
306
0.00%
-0.02%
Motilal Oswal Nifty 500 Index Fund Direct - Growth
0.02%
195
0.00%
0.00%
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth
0.19%
136
0.00%
-0.02%
ICICI Prudential Nifty Smallcap 250 Index Fund Direct - Growth
0.19%
112
0.00%
-0.02%
Mirae Asset Healthcare Fund Direct - Growth
2.48%
-107
0.19%
-0.03%